###begin article-title 0
Lymphotoxin-alpha Gene and Risk of Myocardial Infarction in 6,928 Cases and 2,712 Controls in the ISIS Case-Control Study
###end article-title 0
###begin p 1
###xml 332 337 324 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(LTA)</italic>
###xml 552 555 544 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 993 996 985 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 1070 1071 1062 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1118 1119 1110 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1658 1661 1650 1653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
Lymphotoxin-alpha (LTA) is a pro-inflammatory cytokine that plays an important role in the immune system and local inflammatory response. LTA is expressed in atherosclerotic plaques and has been implicated in the pathogenesis of atherosclerosis and coronary heart disease (CHD). Polymorphisms in the gene encoding lymphotoxin-alpha (LTA) on Chromosome 6p21 have been associated with susceptibility to CHD, but results in different studies appear to be conflicting. We examined the association of seven single nucleotide polymorphisms (SNPs) across the LTA gene, and their related haplotypes, with risk of myocardial infarction (MI) in the International Study of Infarct Survival (ISIS) case-control study involving 6,928 non-fatal MI cases and 2,712 unrelated controls. The seven SNPs (including the rs909253 and rs1041981 SNPs previously implicated in the risk of CHD) were in strong linkage disequilibrium with each other and contributed to six common haplotypes. Some of the haplotypes for LTA were associated with higher plasma concentrations of C-reactive protein (p = 0.004) and lower concentrations of albumin (p = 0.023). However, none of the SNPs or related haplotypes were significantly associated with risk of MI. The results of the ISIS study were considered in the context of six previously published studies that had assessed this association, and this meta-analysis found no significant association with CHD risk using a recessive model and only a modest association using a dominant model (with narrow confidence intervals around these risk estimates). Overall, these studies provide reliable evidence that these common polymorphisms for the LTA gene are not strongly associated with susceptibility to coronary disease.
###end p 1
###begin title 2
Synopsis
###end title 2
###begin p 3
###xml 23 28 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(LTA)</italic>
###xml 248 251 244 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 398 401 394 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 562 565 558 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 742 745 738 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
Lymphotoxin-alpha gene (LTA) encodes a cytokine involved in the immune system that has been linked with risk of coronary heart disease (CHD). In one of the first genome-wide association studies, a Japanese group reported that polymorphisms for the LTA gene were associated with a 1.8-fold higher risk of CHD. The authors of this current paper examined associations of several polymorphisms for the LTA gene with risk of CHD in a case-control study of 6,928 heart attack survivors and 2,712 unrelated controls in the United Kingdom. None of the polymorphisms for LTA (including those examined in the original Japanese study) were associated with CHD risk. Moreover, a meta-analysis of all published studies found no significant association of LTA with CHD risk. These findings emphasize the need for large-scale studies to have sufficient power to detect associations of genetic variants with CHD risk and the need for replication of any such associations in independent studies of even larger size.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 201 202 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b001">1</xref>
###xml 205 208 201 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 366 367 362 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b002">2</xref>
###xml 529 530 525 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b003">3</xref>
###xml 531 532 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b004">4</xref>
Lymphotoxin-alpha (LTA) is a cytokine produced by all cells in the body in response to tissue injury, and it plays an important role in regulation of the immune system and local inflammatory response [1]. LTA and tumour necrosis factor share a common receptor that controls the expression of vascular endothelial cell adhesion molecules and nitric oxide production [2]. LTA is expressed in atherosclerotic plaques in animal models, and has been implicated in the pathogenesis of atherosclerosis and coronary heart disease (CHD) [3,4].
###end p 5
###begin p 6
###xml 273 276 271 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 321 322 319 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b005">5</xref>
###xml 755 756 753 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b005">5</xref>
###xml 876 877 874 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b006">6</xref>
###xml 878 879 876 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b007">7</xref>
###xml 901 902 899 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b008">8</xref>
###xml 903 905 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b010">10</xref>
In an initial genome-wide case-control screen involving 65,671 single nucleotide polymorphisms (SNPs) from 13,738 genes in 94 myocardial infarction (MI) cases and 658 controls in Japan, susceptibility to MI appeared to be associated with the SNP 252A-->G (rs909253) in the LTA gene, which encodes LTA on Chromosome 6p21 [5]. This possible association with rs909253, and with two further SNPs (rs1800683 and rs1041981) in near-perfect linkage disequilibrium (LD) with it, was subsequently replicated by the same investigators in a further 1,133 MI cases and 1,006 controls. Among these SNPs, the non-synonymous coding SNP rs1041981 seemed to be most strongly implicated because of its association with induction of vascular endothelial adhesion molecules [5]. An association of rs909253 or rs1041981 with the risk of CHD has subsequently been observed in some smaller studies [6,7], but not in others [8-10].
###end p 6
###begin p 7
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b011">11</xref>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b012">12</xref>
###xml 466 469 466 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b013">13</xref>
If genetic variants associated with the control of pro-inflammatory cytokines are associated even modestly with MI risk, this could have important implications for understanding the pathogenesis of atherosclerosis. However, reliable confirmation or refutation of such associations typically requires studies involving much larger numbers of cases than in the original hypothesis-generating studies [11,12]. We have examined the association between seven SNPs in the LTA gene, and their related haplotypes, with risk of MI in the large ISIS [13] case-control study, and then included it in a meta-analysis of all previously published reports on this association.
###end p 7
###begin title 8
Results
###end title 8
###begin p 9
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0020107-t001">Table 1</xref>
###xml 81 84 81 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 474 481 470 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0020107-t002">Table 2</xref>
###xml 639 646 635 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0020107-t002">Table 2</xref>
###xml 842 843 838 839 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Table 1 shows the location and relevant characteristics of the seven SNPs in the LTA gene on chromosome 6p21 that were examined in the International Study of Infarct Survival (ISIS) study. Data for six of these SNPs were available in 6,928 cases and 2,712 controls, and for one SNP (rs1041981) in only 6,858 cases and 2,690 controls who had sufficient DNA. The mean age was 54.8 y (standard deviation +/-7.3 y) in cases and 46.2 y (standard deviation +/-9.6 y) in controls (Table 2). The MI cases had a higher mean body mass index (BMI) and higher prevalence of current smokers, hypertension, and diabetes mellitus compared with controls. Table 2 also shows that, compared with controls, MI cases had higher plasma concentrations of apolipoprotein B, fibrinogen, and C-reactive protein (CRP), and lower mean concentrations of apolipoprotein A1 and albumin.
###end p 9
###begin title 10
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
LTA SNPs and Haplotypes
###end title 10
###begin p 11
###xml 30 33 30 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 251 254 251 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 294 297 294 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 503 504 503 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b005">5</xref>
###xml 603 606 603 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 621 622 621 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b009">9</xref>
###xml 623 625 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b010">10</xref>
###xml 628 635 628 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0020107-t003">Table 3</xref>
###xml 728 729 728 729 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</sup>
###xml 780 781 778 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 779 781 777 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
###xml 878 879 876 877 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 877 879 875 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
###xml 986 987 984 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b005">5</xref>
All seven SNPs studied in the LTA gene were in Hardy-Weinberg Equilibrium (HWE) among both cases and controls (unpublished data). Reproducibility of the genotyping was high, with a weighted kappa score of 0.99-1.00 for each of these seven SNPs in the LTA gene (unpublished data). The region of LTA investigated in our study, which spanned about 1 kb and was bounded by rs2071590 and rs1041981, and included all three SNPs examined in the study that had generated the hypothesis of association with CHD [5]. It also included the rs1041981 SNP examined in the PROCARDIS and other published studies of the LTA gene and CHD [9,10]. Table 3 shows that all seven SNPs examined were in high LD, with pair-wise LD measured in terms of DI >/= 0.85 between each SNP. Although the pairwise r2 values between some of the SNPs were low (perhaps due to differences in allele frequency), the r2 values between the rs909253, rs1800683, and rs1041981 SNPs implicated in the hypothesis-generating study [5] were >/=0.98. Hence, all of the SNPs studied were incorporated in the haplotype analysis.
###end p 11
###begin title 12
Associations with CRP, Fibrinogen, and Albumin
###end title 12
###begin p 13
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0020107-t004">Table 4</xref>
###xml 92 95 92 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 532 533 532 533 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Table 4 shows the mean (standard error) values of cardiovascular risk factors by individual LTA haplotypes in the controls. Using the haplotype-based General Linear Model (GLM), statistically significant differences were observed between these haplotypes and plasma concentrations of CRP and albumin (although the absolute differences were generally small), which is consistent with some of these SNPs being functional. There were no significant differences between the haplotypes in BMI or plasma concentrations of apolipoprotein A1, apolipoprotein B, or fibrinogen.
###end p 13
###begin title 14
Association with MI Risk
###end title 14
###begin p 15
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0020107-t005">Table 5</xref>
###xml 105 108 105 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 287 290 287 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 330 331 330 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b005">5</xref>
###xml 632 653 632 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 698 701 698 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 739 740 737 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 767 768 763 764 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 768 769 764 765 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 778 779 774 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Table 5 displays the associations with MI risk in the ISIS case-control study for individual SNPs of the LTA gene, after adjustment for age and sex, when analyzed using co-dominant, recessive, and dominant genetic models, respectively. Neither the rs909253 nor the rs1041981 SNP for the LTA gene that was studied by Ozaki et al. [5] was significantly associated with MI risk using any of the genetic models. Although the most frequent genotype has been used as the reference category, any group can be compared with any other since each is displayed with its appropriate confidence interval (CI) using "floated" absolute risks (see Materials and Methods). None of the individual haplotypes for the LTA gene was associated with MI risk (chi2 test of heterogeneity: chi26 = 7.97, p = 0.24) (unpublished data).
###end p 15
###begin title 16
Comparison with Other Studies
###end title 16
###begin p 17
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020107-g001">Figure 1</xref>
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b005">5</xref>
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b010">10</xref>
###xml 220 221 220 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b005">5</xref>
###xml 222 223 222 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b006">6</xref>
###xml 224 225 224 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b008">8</xref>
###xml 274 275 274 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b005">5</xref>
###xml 276 277 276 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b007">7</xref>
###xml 278 279 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b009">9</xref>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b010">10</xref>
###xml 347 348 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b008">8</xref>
###xml 469 477 469 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020107-g001">Figure 1</xref>
###xml 664 672 664 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020107-g001">Figure 1</xref>
###xml 724 725 724 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b005">5</xref>
###xml 810 818 810 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020107-g001">Figure 1</xref>
###xml 898 906 898 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020107-g001">Figure 1</xref>
###xml 1024 1025 1022 1023 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1025 1026 1023 1024 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 1034 1035 1032 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1138 1139 1134 1135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1139 1140 1135 1136 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1148 1149 1144 1145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1260 1261 1254 1255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1261 1262 1255 1256 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 1271 1272 1265 1266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1338 1339 1330 1331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1339 1340 1331 1332 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1348 1349 1340 1341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1405 1406 1395 1396 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1406 1407 1396 1397 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1415 1416 1405 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Figure 1 shows the associations of CHD risk with rs909253 or rs1041981 in all previously published studies [5-10] and in the present ISIS study. Among the six previous studies, three examined associations with rs909253 [5,6,8] and four examined associations with rs1041981 [5,7,9,10] (and one study reported data separately for males and females [8]). For the ISIS case-control study (without adjustment for age and sex), the association with rs1041981 is displayed in Figure 1, but that SNP was in near perfect LD with rs909253 (which had an odds ratio for MI of 0.99 [99% CI: 0.83-1.17] in a recessive model and 1.00 [99% CI: 0.89-1.13] in a dominant model: see Figure 1). After excluding the hypothesis-generating study [5], the combined odds ratio in a recessive model was 1.07 with a 95% CI of 0.98-1.17 (Figure 1A), and in an autosomal dominant model, it was 1.09 with a 95% CI of 1.02-1.16 (Figure 1B). For the recessive model, there was no significant heterogeneity between the results of the individual studies (chi26 = 9.9, p = 0.1), although there was a highly significant trend towards the null with increasing study size (chi21 = 7.0, p = 0.008). For the dominant model, there was significant heterogeneity between the different study results (chi26 = 18.0, p = 0.007), but this chiefly reflected a trend with study size (chi21 = 9.9, p = 0.002) and no significant residual heterogeneity (chi25 = 8.1, p = 0.1). Inclusion of the ISIS results for rs909253 instead of rs1041981 did not change the results of this meta-analysis materially, with a combined odds ratio of 1.06 (95% CI: 0.97-1.16) in the recessive model and 1.08 (95% CI: 1.02-1.15) in the dominant model.
###end p 17
###begin title 18
Discussion
###end title 18
###begin p 19
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA,</italic>
###xml 278 299 278 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 462 463 462 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b005">5</xref>
###xml 549 570 549 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 623 626 623 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 264 272 <span type="species:ncbi:9606">children</span>
The ISIS study is the largest genetic association study of MI risk and polymorphisms in LTA, involving 6,928 MI cases and 2,712 unrelated controls. The recruitment procedure used for controls in the ISIS case-control study (involving spouses of siblings and their children: see Materials and Methods) should have minimised the risk of population admixture between controls and cases. The seven SNPs studied included three that had been previously been reported [5], as well as others identified by resequencing to be in high LD with each other (see Materials and Methods), and covered a genomic region of about 1 kb in the LTA gene. The ISIS case-control study found no significant association of MI risk with any of these individual SNPs or with any of the six common haplotypes studied (including those associated with significantly higher plasma concentrations of CRP and albumin).
###end p 19
###begin p 20
###xml 75 76 75 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b005">5</xref>
###xml 160 163 160 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 590 593 590 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 701 702 701 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b005">5</xref>
###xml 1120 1121 1120 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b005">5</xref>
###xml 1172 1174 1172 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b014">14</xref>
###xml 1363 1364 1363 1364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b006">6</xref>
###xml 1394 1395 1394 1395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b008">8</xref>
The present findings differ from those of the hypothesis-generating study [5] which reported that, in a recessive model, the SNPs rs909253 and rs1800683 in the LTA gene were associated with odds ratios for MI of 1.71 (95% CI: 1.24-2.36) and 1.78 (95% CI: 1.39-2.27), respectively. That study used a two-stage design in which 65,671 genetic markers in 13,738 genes were initially screened in 94 MI cases and 658 controls, and then the 1% of markers that appeared most strongly associated with MI were re-examined in a further 1,133 MI cases and 1,006 controls. In that study, a third SNP in LTA (rs1041981) also appeared to be associated with risk of MI with an odds ratio of 1.78 (95% CI: 1.39-2.27) [5]. It is possible that those results represented false-positive results identified among the relatively small number of cases. Alternatively, it may reflect an imbalance in the control population which was selected from several different population sources, since significant departures from Hardy-Weinberg equilibrium were observed in the genotype distributions in case and control samples in the Ozaki et al. study [5] (possibly indicating population stratification) [14]. Two further case-control studies carried out in Japanese populations have reported conflicting results, with one appearing to confirm an association of the rs909253 SNP with risk of MI [6] and the other not doing so [8].
###end p 20
###begin p 21
###xml 207 208 207 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b007">7</xref>
###xml 652 654 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b010">10</xref>
In a multicentre European study of 400 trio families, the PROCARDIS Consortium reported that rs1041981 was associated in a recessive model with a 1.96 (95% CI: 1.25-3.13) higher risk of CHD before age 65 y [7]. In principle, a study design involving the use of trios should eliminate the potential risk of population admixture that may occur in unrelated case-control studies. However, the apparent association in PROCARDIS could still reflect the play of chance in a study involving relatively small numbers of diseased cases. A subsequent larger, trio family study of 671 UK families reported no significant association of rs1041981 with risk of MI [10].
###end p 21
###begin p 22
###xml 106 109 106 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b012">12</xref>
###xml 381 384 381 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 526 527 526 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b007">7</xref>
###xml 725 728 725 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 827 829 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b015">15</xref>
###xml 1024 1025 1024 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b008">8</xref>
###xml 1070 1072 1070 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b010">10</xref>
###xml 1245 1248 1245 1248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 1429 1437 <span type="species:ncbi:9606">children</span>
###xml 1482 1494 <span type="species:ncbi:9606">participants</span>
An alternative explanation for these apparently discrepant findings might be that none of the SNPs in the LTA gene studied by Ozaki et al. is causally associated with MI, but are instead in high LD with some other SNP which is present in higher frequency in Japanese than in populations of European descent [12]. In such circumstances, detection of this association via the common LTA SNPs would be facilitated in Japanese populations. There would also be a better chance of observing it in trio families of European descent [7], since a sampling strategy based on at least one family member suffering an MI would inflate the frequency of a causal allele that is otherwise rare in the general population. Lack of SNPs in the LTA gene that were genotyped in both the European-descentand Japanese populations in HapMap Phase II [15] did not allow us to investigate the possibility of differential LD patterns between the two populations. However, the absence of an association in a large Japanese population by Yamada et al. [8] and in another large UK trio family study [10] does not support this alternative hypothesis. The ISIS study had more than 90% power to detect a 10% higher risk of MI associated with rs909253 and rs1041981 SNPs for the LTA gene (assuming an allele frequency of about 0.35) using co-dominant or recessive genetic models. The selection of controls in the ISIS study from spouses of siblings or spouses of children, together with the very small proportion of participants of non-European descent in this study would indicate that the risk of population stratification is small.
###end p 22
###begin p 23
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b011">11</xref>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b012">12</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b016">16</xref>
###xml 430 433 430 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 916 919 916 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 1085 1088 1085 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
A major problem in genetic association studies has been the high proportion of false-positive results suggested by studies involving relatively small numbers of diseased cases [11,12]. Attenuation in the strength of the observed association in larger studies is consistent with publication bias, whereby more extreme results are more likely to be published earlier [16]. The apparent discrepancy between the results of studies of LTA and CHD risk reinforces the need for studies involving larger numbers of disease cases, unrelated controls selected from the same population as the cases, and genotyping of markers that provide good coverage of the gene of interest. The ISIS case-control study of nearly 7,000 cases with MI before age 65 y and of family-based controls, considered in the context of previously reported studies of this association, provides reliable evidence that these common polymorphisms for the LTA gene are not strongly associated with susceptibility to coronary disease. The present study cannot exclude the possibility of involvement of other variants near the LTA gene (e.g., in more distal regulatory regions), which were not considered.
###end p 23
###begin title 24
Materials and Methods
###end title 24
###begin title 25
Study population.
###end title 25
###begin p 26
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b017">17</xref>
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b018">18</xref>
###xml 1115 1117 1115 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b019">19</xref>
###xml 141 144 <span type="species:ncbi:9606">men</span>
###xml 162 167 <span type="species:ncbi:9606">women</span>
###xml 504 512 <span type="species:ncbi:9606">children</span>
###xml 707 715 <span type="species:ncbi:9606">children</span>
###xml 1121 1133 <span type="species:ncbi:9606">Participants</span>
The design of the ISIS case-control study has been described in detail in previous publications [17,18]. Cases genotyped for this study were men aged 30-54 y and women aged 30-64 y, with non-fatal MI confirmed by cardiac enzyme or electrocardiographic criteria (or both). Blood was collected on admission to hospital with their index MI, and a few months later, information was sought from surviving cases about aspects of their previous lifestyle. A similar questionnaire was sent to their siblings and children older than 30 y, and to the spouses of those relatives, with blood sought from all those who completed a questionnaire. Controls genotyped in the present study were spouses of their siblings or children (i.e., unrelated to the MI cases except by marriage) aged 30-64 y, and with no history of MI, angina, or other definite heart disease. Ethnicity was not recorded, but the family-based recruitment strategy should have yielded similar distributions among cases and controls (and, based on other studies conducted by us in these UK hospitals, more than 95% would be expected to be of European descent [19]). Participants provided consent to participate in the study, which had research ethics committee approval.
###end p 26
###begin title 27
Laboratory methods.
###end title 27
###begin p 28
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b017">17</xref>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b018">18</xref>
###xml 138 141 138 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 317 320 317 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
DNA was extracted from frozen buffy coat samples using a Taqman and amplifluor technique, as previously described [17,18]. Seven SNPs for LTA (rs2071590, rs1800683, rs909253, rs746868, rs2857713, rs3093543, and rs1041981) were selected, including those typed in previous studies, from among all 22 known SNPs for the LTA gene in the National Center for Biotechnology Information (NCBI) genome assembly 35. Genotyping using mass spectrometry was carried out at the Centre Nationale de Genotypage (CNG) in Paris without knowledge of disease status, with samples from cases and controls distributed within each 384-well genotyping plate. Internal controls were used to check the consistency of genotyping between plates, and the reproducibility of genotyping was assessed by replicate measurements in a random sample of 250 controls.
###end p 28
###begin p 29
###xml 41 42 41 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b020">20</xref>
###xml 839 841 839 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b020">20</xref>
###xml 1124 1126 1124 1126 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1,</sub>
Plasma concentrations of apolipoprotein A1 and apolipoprotein B were measured at the Clinical Trial Service Unit (CTSU) using Immuno reagents (Vienna, Austria) on Beckman Synchron CX4 and CX5 auto-analysers (Beckman Coulter UK, Limited, High Wycombe, England, United Kingdom). Albumin concentrations were also measured on these auto-analysers using a colorimetric method. A sample blank absorbance reading was subtracted from the final reaction absorbance to correct any interference due to haemolysis prior to sample separation [20]. Fibrinogen and high sensitivity CRP concentrations were measured using Dade-Behring reagents on an automated Dade-Behring Nephelometer II analyser (Dade-Behring GmbH, Marburg, Germany). Previous studies had indicated small changes in measured levels of plasma analytes due to delay in plasma separation [20] ,so the analyses were adjusted for time from collection to separation, as well as for date of assay to allow for any slight analyser drift. The intra-assay coefficients of variation, based on repeat analyses of control material, were 3%-4% for all plasma analytes (apolipoprotein A1, apolipoprotein B, albumin, fibrinogen, and CRP).
###end p 29
###begin title 30
Statistical analysis.
###end title 30
###begin p 31
###xml 158 159 158 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 302 303 302 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</sup>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b021">21</xref>
###xml 328 329 328 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 326 330 326 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(r<sup>2</sup>)</italic>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b022">22</xref>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b023">23</xref>
###xml 1329 1331 1329 1331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b024">24</xref>
###xml 1332 1334 1332 1334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b025">25</xref>
###xml 1477 1480 1477 1480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
###xml 1525 1527 1525 1527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b026">26</xref>
###xml 1528 1530 1528 1530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b027">27</xref>
The genotypic distributions of each SNP were assessed for HWE in cases and controls separately using an exact chi-square goodness of fit test. A threshold of p < 0.05 was used to indicate departure from HWE. Allelic association, or LD, between SNPs was assessed using the standardised disequilibrium (DI) [21] and correlation (r2) [22] coefficients. The maximum likelihood estimates of haplotype frequencies and posterior probabilities of pairs of haplotypes were estimated for each individual with an expectation-maximization (E-M) algorithm under the HWE assumption using the Haplostats suite of software in R [23]. Haplotypes with an estimated frequency >1% were analyzed separately, and the remaining haplotypes were combined. A weighted kappa score was used to assess reproducibility of each of the individual SNPs studied. Analysis of variance was used to assess the associations of haplotypes with levels of cardiovascular risk factors in controls. Logistic regression adjusted for age and sex was used to estimate odds ratios for MI of each SNP and haplotype. Floated absolute risks and CIs were used to share the variance of the log odds ratios appropriately between the different genotypes or haplotypes, which allows a CI to be computed for the reference category and any group to be compared directly with any other [24,25]. The power calculations for the ISIS case-control study to detect associations of MI risk with either the rs909253 or rs10412981 SNP for the LTA gene were estimated using standard methods [26,27].
###end p 31
###begin p 32
###xml 622 623 622 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b005">5</xref>
###xml 799 801 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b016">16</xref>
###xml 802 804 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b028">28</xref>
###xml 977 979 977 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b029">29</xref>
Finally, a meta-analysis was conducted of the associations between rs909253 or rs1041981 (which are in perfect LD in Japanese and European-descent populations) and the incidence of CHD in the ISIS study and all other published studies. For the latter studies, odds ratios for CHD were calculated from the published number of cases and controls in each of the genotype categories, either assuming an autosomal dominant model (homozygous and heterozygous vs. wild type) or recessive model (homozygous vs. heterozygous and wild type). Since the Ozaki et al. study using a recessive model was the hypothesis-generating study [5], it was not included in the combined results for the meta-analysis. The results for all remaining studies were assessed for heterogeneity and for linear trend by study size [16,28]. Summary estimates of the odds ratios from all studies were obtained by combining the separate estimates of the inverse variance-weighted log odds ratios from each study [29]. To minimise the risk of false-positive results associated with multiple comparisons, 99% confidence intervals were used for individual studies and 95% CIs for the sub-totals. All analyses were carried out using SAS version 8.2 (Cary, North Carolina, United States) and R version 1.9.1 ().
###end p 32
###begin p 33
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b013">13</xref>
###xml 55 63 <span type="species:ncbi:9606">patients</span>
###xml 572 577 <span type="species:ncbi:9606">Human</span>
The chief acknowledgement for the ISIS study is to the patients and their relatives who collaborated, to their general practitioners, and to the medical and nursing staff from more than 100 hospitals in the UK. A full list of the participating centres and collaborators is given in the ISIS-3 report [13]. We thank Peter Sleight (Chairman of the ISIS Steering Committee) and Paul Sherliker (for producing the figures) of the Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, respectively, and Fiona Green of the Wellcome Trust Centre for Human Genetics, Oxford.
###end p 33
###begin title 34
Abbreviations
###end title 34
###begin p 35
body mass index
###end p 35
###begin p 36
coronary heart disease
###end p 36
###begin p 37
confidence interval
###end p 37
###begin p 38
C-reactive protein
###end p 38
###begin p 39
Hardy-Weinberg Equilibrium
###end p 39
###begin p 40
International Study of Infarct Survival
###end p 40
###begin p 41
linkage disequilibrium
###end p 41
###begin p 42
lymphotoxin-alpha
###end p 42
###begin p 43
myocardial infarction
###end p 43
###begin p 44
single nucleotide polymorphism
###end p 44
###begin title 45
References
###end title 45
###begin article-title 46
Regulation of autoimmunity by proinflammatory cytokines
###end article-title 46
###begin article-title 47
The role of tumour necrosis factor-alpha receptors in atherosclerosis
###end article-title 47
###begin article-title 48
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 62 67 <span type="species:ncbi:9606">human</span>
Detection and localization of human tumour necrosis factor in human atheroma
###end article-title 48
###begin article-title 49
###xml 90 94 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Loss of lymphotoxin-alpha but not tumour necrosis factor-alpha reduces atherosclerosis in mice
###end article-title 49
###begin article-title 50
Functional SNP's in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction
###end article-title 50
###begin article-title 51
Association analysis between polymorphisms of the lymphotoxin-alpha gene and myocardial infarction in a Japanese population
###end article-title 51
###begin article-title 52
A trio family study showing association of the lymphotoxin-alpha N26 (804A) allele with coronary artery disease
###end article-title 52
###begin article-title 53
Lack of association of polymorphisms of the lymphotoxin-alpha gene with myocardial infarction in Japanese
###end article-title 53
###begin article-title 54
Genotypes and haplotypes predisposing to myocardial infarction: A multilocus case-control study
###end article-title 54
###begin article-title 55
Lack of association between premature myocardial infarction and the lymphotoxin-alpha C804A polymorphism in a UK discordant sibling population
###end article-title 55
###begin article-title 56
The complex interplay among factors that influence allelic association
###end article-title 56
###begin article-title 57
###xml 15 20 <span type="species:ncbi:9606">human</span>
The effects of human population structure on large genetic association studies
###end article-title 57
###begin article-title 58
ISIS-3: A randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction
###end article-title 58
###begin article-title 59
Rational inferences about departures from Hardy-Weinberg equilibrium
###end article-title 59
###begin article-title 60
###xml 23 28 <span type="species:ncbi:9606">human</span>
A haplotype map of the human genome
###end article-title 60
###begin article-title 61
Investigating and dealing with publication and other biases in meta-analysis
###end article-title 61
###begin article-title 62
Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators
###end article-title 62
###begin article-title 63
Lipid-related genes and myocardial infarction in 4685 cases and 3460 controls: Discrepancies between genotype, blood lipid concentrations, and coronary disease risk
###end article-title 63
###begin article-title 64
###xml 117 125 <span type="species:ncbi:9606">patients</span>
MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience
###end article-title 64
###begin article-title 65
Stability of plasma analytes after delayed separation of whole blood: Implications for epidemiological studies
###end article-title 65
###begin article-title 66
On measures of gametic disequilibrium
###end article-title 66
###begin article-title 67
Linkage disequilibrium in finite populations
###end article-title 67
###begin article-title 68
Score tests for association between traits and haplotypes when linkage phase is ambiguous
###end article-title 68
###begin article-title 69
Floating absolute risk: An alternative to relative risk in survival in case-control analysis avoiding an arbitrary reference group
###end article-title 69
###begin article-title 70
Improved estimates of floating absolute risk
###end article-title 70
###begin article-title 71
Case-control studies of genetic markers: power and sample size approximations for Armitage's test for trend
###end article-title 71
###begin article-title 72
Trend tests for case-control studies of genetic markers: Power, sample size and robustness
###end article-title 72
###begin article-title 73
Why sources of heterogeneity in meta-analysis should be investigated
###end article-title 73
###begin article-title 74
Beta blockade during and after myocardial infarction: An overview of the randomized trials
###end article-title 74
###begin title 75
Figures and Tables
###end title 75
###begin title 76
###xml 76 79 76 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
Odds ratio (CI) for Coronary Heart Disease Associated with Genotypes of the LTA Gene in ISIS and Other Studies Using Recessive and Dominant Models
###end title 76
###begin p 77
###xml 186 187 186 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020107-b005">5</xref>
(A) shows the recessive model and (B) shows the dominant model. Studies are of either the rs909253 SNP (A/G alleles) or the rs1041981 SNP (A/C alleles). The hypothesis-generating study [5] has been excluded from the combined estimates for all other studies that tested the hypothesised association. Size of the squares is proportional to the variance of the log odds ratio, and horizontal lines represent the 99% CIs, and the width of the diamonds represents the 95% CIs. The associations have not been adjusted for age or sex.
###end p 77
###begin p 78
###xml 48 51 48 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
Identity and Base-Pair Position of SNPs for the LTA Gene on Chromosome 6, and Minor Allele Frequencies in Controls in the ISIS Study
###end p 78
###begin p 79
Characteristics of Confirmed Myocardial Infarction Cases and Controls (Mean [SD] or %)
###end p 79
###begin p 80
###xml 40 41 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</sup>
###xml 61 62 61 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(r<sup>2</sup>)</italic>
###xml 110 113 110 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
Pair-Wise Standardised Disequilibrium (DI) and Correlation (r2) Coefficients, between Individual SNPs for the LTA Gene
###end p 80
###begin p 81
###xml 68 71 68 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
Mean (SE) Values for Selected Characteristics by Haplotypes for the LTA Gene in Controls
###end p 81
###begin p 82
###xml 51 54 51 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LTA</italic>
Odds Ratio (95% CI) of MI Associated with SNPs for LTA in ISIS Study (Adjusted for Age and Sex)
###end p 82
###begin p 83
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. R. Clarke, P. Xu, D. Bennett, S. Parish, R. Peto, M. Lathrop, and R. Collins conceived and designed the experiments. R. Clarke, P. Xu, D. Bennett, S. Clark, M. Lathrop, and R. Collins performed the experiments. R. Clarke, P. Xu, D. Bennett, S. Lewington, K. Zondervan, S. Parish, A. Palmer, L. Cardon, M. Lathrop, and R. Collins analyzed the data. R. Clarke, P. Xu, R. Peto, M. Lathrop, and R. Collins contributed reagents/materials/analysis tools. R. Clarke, P. Xu, D. Bennett, S. Lewington, K. Zondervan, S. Parish, A. Palmer, L. Cardon, R. Peto, M. Lathrop, and R. Collins wrote the paper.
###end p 83
###begin p 84
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 84
###begin p 85
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
###xml 204 211 <span type="species:ncbi:4097">Tobacco</span>
Funding. The ISIS trials and epidemiological studies were supported by the manufacturers of the study drugs, and by the British Heart Foundation, Medical Research Council, Cancer Research United Kingdom, Tobacco Products Research Trust of the UK Department of Health Independent Scientific Committee on Smoking and Health, and Oxford National Health Service Genetic Knowledge Park.
###end p 85

